目的 利用基因检测技术对拟诊先天性肌营养不良(CMD)患儿进行明确诊断,为CMD的早期诊断提供参考。方法 收集1例拟诊CMD患儿临床资料,采集患儿及父母血标本,采用基因测序检测致病基因。结果 该患儿于出生后发病,运动发育落后、肌张力降低,血清肌酸激酶升高,肌电图示肌源性损害,肌肉组织呈典型先天性肌营养不良样的病理改变,头颅MRI示双侧额颞部脑沟及蛛网膜下腔较宽。基因测序发现LAMA2基因c.3735+2-3735+8delinsAAAGAAGGA纯合剪切变异,来自于患儿父亲,经基因检测确诊为先天性肌营养不良1A型(MDC1A)。结论 若患儿临床表现为运动发育落后,肌酸激酶增高及肌电图提示肌源性损害应考虑CMD,可行基因检测以明确诊断。
Abstract
Objective To perform prenatal gene diagnosis on sporadic case with congenital muscular dystrophy(CMD). Method The clinical data of 1 patient with CMD and blood samples of the child and parents were collected,pathogenic genes were detected using gene sequencing. Results The child with the onset of after birth,appeared motor retardation,hypotonia,increased of serum creatine kinase.EMG showed myogenic damage.Cranial MRI showed that the bilateral frontal and temporal cerebral sulcus and subarachnoid space were wider.Gene sequencing revealed that the c.3735+2-3735+8delinsAAAGAAGGA gene LAMA2 homozygous mutated from the children's father.The genetic test confirmed the diagnosis of MDC1A. Conclusions If the child's clinical manifestations of motor retardation,increased creatine kinase and EMG showed myogenic damage,CMD should be promptly considered,and early genetic testing can confirm the diagnosis.
关键词
先天性肌营养不良 /
LAMA2基因 /
生殖腺嵌合 /
基因突变 /
层黏连蛋白
Key words
congenital muscular dystrophy /
LAMA2 /
germline mosaicism /
mutation /
merosin
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Sparks S,Quijano-Roy S,Harper A,et al.Congenital muscular dystrophy overview[J].Gene,2012.http://www.ncbi.nlm.nih.gov/books/NBK1291/
[2] Pagon RA,Adam MP,Ardinger HH,et al.LAMA2-related muscular dystrophy[J].Gene,2012.http://www.ncbi.nlm.nih.gov/books/NBK97333/
[3] 杨璐,王爽,熊晖.基因检测诊断LAMA2基因突变所致先天性肌营养不良1例[J].中华实用儿科临床杂志,2015,30(12):952-953
[4] Kim HJ,Choi YC,Park HJ,et al.Congenital muscular dystrophy type 1A with residual merosin expression[J].Korean Journal of Pediatrics,2014,57(3):149-152.
[5] Camacho A,Núñez N,Dekomien G,et al.LAMA2-related congenital muscular dystrophy complicated by West syndrome[J].European Journal of Paediatric Neurology,2015,19(2):243-247.
[6] Susana QJ,Francis R,Norma R,et al.EMG and nerve conduction studies in children with congenital muscular dystrophy[J].Muscle & Nerve,2004,29(29):292-299.
[7] Yuan J,Takashima H,Higuchi I,et al.Genetically confirmed patients with merosin-deficient congenital muscular dystrophy in China[J].Neuropediatrics,2008,39(5):264-267.
[8] Oliveira J,Santos R,Soares-Silva I,et al.LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients[J].Clinical Genetics,2008,74(6):502-512.
[9] Geranmayeh F,Clement E,Feng LH,et al.Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations[J].Neuromuscular Disorders,2010,20(4):241-250.
[10] Armaroli A,Trabanelli C,Scotton C,et al.Paternal germline mosaicism in collagen VI related myopathies[J].European Journal of Paediatric Neurology Ejpn Official Journal of the European Paediatric Neurology Society,2015,19(5):533-536.
[11] Tiemo G,Wolfram K,Gerhard M,et al.Risk assessment and genetic counseling in families with Duchenne muscular dystrophy[J].Acta Myologica,2012,31(3):179-183.
[12] Makri S,Clarke NF,Richard P,et al.Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy[J].Neuromuscular Disorders Nmd,2009,19(1):26-28.
[13] Brockington M,Blake DJ,Prandini P,et al.Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan[J].American Journal of Human Genetics,2001,69(6):882-886.
PDF(534 KB)
